Close

Lilly's (LLY) Humulin R U-500 KwikPen Approved by U.S. FDA

January 21, 2016 10:09 AM EST Send to a Friend
The U.S. Food and Drug Administration (FDA) has approved Eli Lilly and Company's (NYSE: LLY) Humulin R U-500 KwikPen ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login